History of HOCL

Hypochlorous acid (HOCL) was identified in 1834 by a French chemist, Antoine Jérôme Balard and was used as an antiseptic for traumatic wounds in World Wars I and II. Environmental sanitation applications were later developed to aid gangrene, diphtheria and scarlet fever.

Decades later came the discovery that HOCL is naturally formed within human neutrophils. Its biocidal properties are very powerful and its benefits are endless.

HOCL is documented with numerous studies of how it has excelled in professional fields such as ophthalmology, dentistry, veterinary, and wound care. HOCL has proven to be highly effective against viruses such as SARS-CoV 2, E. coli, Salmonella, Listeria, MRSA, Norovirus, H1N1, Staph/VRE, Pseudomonas, and all Avian Flus, even at lower concentrations. It is also recognized and regulated by the FDA, CDC, EPA, NSF, and USDA.